'
Then an offer came along to join the first Australian trial of an experimental treatment for men with advanced prostate cancer who had exhausted all their options. It was for a disruptive technology in the field of nuclear medicine.
Findlay, 78, happened to be a perfect candidate. In October and November he had two cycles of the treatment and, as the second scan shows, his cancer temporarily vanished and his PSA dropped to seven, almost within the normal range for his age.
He was back with the living. His wife Robyn, a former oncology nurse at Melbourne's Peter MacCallum Cancer Centre, said she'd never seen anything work like this before.
"Within a week he was up and cleaning the garage, without painkillers."
According to the trial protocol. Findlay was supposed to have another two cycles before six months was up, but he didn't seem to need them. So treatment was halted while his doctors kept watch.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)